Cell Signaling Technology

Product Pathways - Lymphocyte Signaling

CD79A Antibody #3351

Applications Reactivity Sensitivity MW (kDa) Source
W IHC-P IF-IC H Endogenous 45-55 Rabbit

Applications Key:  W=Western Blotting  IHC-P=Immunohistochemistry (Paraffin)  IF-IC=Immunofluorescence (Immunocytochemistry)
Reactivity Key:  H=Human
Species cross-reactivity is determined by Western blot.

Protocols

Specificity / Sensitivity

CD79A Antibody detects endogenous levels of total CD79A protein.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Asn217 of human CD79A. Antibodies are purified by peptide affinity chromatography

Western Blotting

Western Blotting

Western blot analysis of extracts from Raji and Daudi cell lines using CD79A Antibody.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded Raji (left) and Jurkat (right) cells using CD79A Antibody. Note: Jurkat cells lack CD79A protein.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human tonsil using CD79A Antibody in the presence of control peptide (left) or antigen-specific peptide (right).


IF-IC

IF-IC

Confocal immunofluorescent analysis of Ramos (left) and Jurkat cells (right) using CD79A Antibody (green). Blue pseudocolor= DRAQ5® #4084 (fluorescent DNA dye).

Background

Antigen receptors found on the surface of B-cells contain a hetrodimeric signaling component composed of CD79A and CD79B, also known as Ig α and Ig β, respectively (1,2). Presence of this receptor complex is essential for B-cell development and function (3). Together these two proteins and the associated B cell receptor initiate intracellular signaling following antigen binding (4,5). An immunoreceptor tyrosine-based activation motif (ITAM) is found in the CD79A intracellular region appears to be is important for its function (6). Antigen binding precedes formation of the CD79A and CD79B heterodimer and subsequent activation of receptor associated kinases (7). CD79A is a marker for B-lineage lymphoblastic leukemia (8); mutations in the corresponding mb-1 gene are responsible for abnormally low levels of functional B cell receptors in some cases of chronic B-cell lymphocytic leukemia (9).

  1. van Noesel, C.J. et al. (1991) J Immunol 146, 3881-8.
  2. Minegishi, Y. et al. (1999) J Clin Invest 104, 1115-21.
  3. Yu, L.M. and Chang, T.W. (1992) J Immunol 148, 633-7.
  4. Storch, B. et al. (2007) Eur J Immunol 37, 252-60.
  5. Mason, D.Y. et al. (1995) Blood 86, 1453-9.
  6. Luisiri, P. et al. (1996) J Biol Chem 271, 5158-63.
  7. Pike, K.A. et al. (2004) J Immunol 172, 2210-8.
  8. Astsaturov, I.A. et al. (1996) Leukemia 10, 769-73.
  9. Vuillier, F. et al. (2005) Blood 105, 2933-40.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.

Products